Bacterial resistance to antibiotics has become a major public health issue. A recent report, coordinated by Jean Carlet and delivered to the Minister of Health in September 2015, pointed out 158,000 cases of infections by multidrug-resistant germ annually in France, 16,000 invasive infections (meningitis, bacteremia / septicemia) and nearly 12,000 deaths per year directly associated with these infections. These estimates are from the Burden BMR study conducted by the Institute of Health Surveillance.
The PHIBRA (Public Health Impact of the Bacterial Resistance to Antibiotics) program focuses on the consequences, including economic consequences, of bacterial resistance to antibiotics in France. A component of this program is based on the medico-administrative databases (SNIIRAM) to investigate the epidemiological cost in terms of mortality, duration of hospitalization, post-hospital care, etc. and additional economic cost linked to the presence of antibiotic-resistant bacteria during the infection.
This project is funded by the Direction Générale de la Santé (DGS).
Keywords: Bacterial resistance to antibiotics, Invasive infection, SNIIRAM
- Kristel Cosker, AP-HP
- Grégoire de Lagasnerie, DSS, Ministère des Affaires Sociales et de la Santé
- Philippe Tuppin, CNAMTS